Group 1 - The company has nominated Ms. Qiu Wenli as a non-independent director for the eighth board, pending approval at the upcoming shareholders' meeting [1][3] - The board meeting on January 20, 2026, approved the nomination and will submit it for shareholder approval [1][11] - After the approval, the board will consist of nine members, with the number of executive directors and employee representatives not exceeding half of the total board members [1] Group 2 - The company has decided to dismiss its accounting firm, Zhongxing Caiguanghua, due to an ongoing investigation by the China Securities Regulatory Commission [4][6] - The firm has been providing audit services since 2011 and issued an unqualified audit report for the 2024 financial year [7][8] - The dismissal requires approval from the shareholders' meeting scheduled for February 5, 2026, and the company is in the process of selecting a new auditing firm [12][11] Group 3 - The first temporary shareholders' meeting of 2026 is scheduled for February 5, 2026, with both on-site and online voting options available [14][18] - The meeting will discuss the approval of the nomination of Ms. Qiu Wenli and the dismissal of the accounting firm [35][34] - Shareholders must register for the meeting by January 29, 2026, and can delegate their voting rights to a proxy [23][25]

Core Viewpoint - The company held its fourth temporary board meeting of the eleventh session, where several key resolutions were passed, including the reappointment of an accounting firm and the election of a new committee member [1][2][7][22]. Group 1: Board Meeting Resolutions - The board approved the election of Mr. Luo Liang as a member of the Audit Committee and the Remuneration and Appraisal Committee, effective immediately [2]. - The composition of the Audit Committee after the election includes Luo Chunhua, Jin Xiaogang, Zheng Chunyan, You Kuangling, and Luo Liang, with Luo Chunhua as the convener [3]. - The Strategic Committee consists of You Kuangling, Jin Xiaogang, Luo Chunhua, Zheng Chunyan, and Tang Ying, with You Kuangling as the convener [4]. - The Remuneration and Appraisal Committee includes Jin Xiaogang, Luo Chunhua, Zheng Chunyan, Wang Yingyi, and Luo Liang, with Jin Xiaogang as the convener [5]. - All resolutions were passed with unanimous support, receiving 7 votes in favor, 0 against, and 0 abstentions [6][8][11]. Group 2: Reappointment of Accounting Firm - The board approved the reappointment of Zhonghui Certified Public Accountants (Special General Partnership) as the company's accounting firm for the year 2025 [7][22]. - Zhonghui Certified Public Accountants has been in operation since December 2013 and has a strong background in securities services, with 694 registered accountants and 289 who have signed audit reports for securities services [15][16]. - The total audit fee for 2025 is set at 1.8 million yuan, which includes 1.35 million yuan for financial audits and 450,000 yuan for internal control audits [20]. - The reappointment is subject to approval at the upcoming shareholders' meeting [23]. Group 3: Upcoming Shareholders' Meeting - The first temporary shareholders' meeting for 2026 is scheduled for January 5, 2026, at 14:00, combining on-site and online voting methods [26]. - The meeting will take place at a specified location in Beijing, and shareholders can vote through the Shanghai Stock Exchange's online voting system [26][27]. - The meeting will address the resolutions passed in the board meeting, which have been disclosed on the Shanghai Stock Exchange's website [29].

Group 1 - The company held a temporary board meeting where all five participating directors voted in favor of several key proposals [1][2][3] - The company plans to appoint Jiang Xin and Zhou Yanqi as non-independent directors, pending approval at the first temporary shareholders' meeting in 2025 [1][2] - The company intends to change its name to "Guhan Health Industry Group Co., Ltd." to better reflect its main business and enhance brand recognition [2][3] Group 2 - The company expects to engage in daily operational related transactions with its shareholder's affiliate, Hunan Hengchang Pharmaceutical Group Co., Ltd., with a total transaction amount not exceeding 50 million yuan in 2025 [2][3] - A temporary shareholders' meeting is scheduled for September 22, 2025, to discuss the aforementioned proposals [3][4] - All proposals from the board meeting require approval at the upcoming shareholders' meeting [4]

Meeting Overview - The company will hold its first extraordinary general meeting of 2025 on September 8, 2025 [1][2] - The meeting will be convened by the board of directors and is compliant with relevant laws and regulations [1][10] Meeting Details - The meeting will take place at 2:45 PM on September 8, 2025, with network voting available throughout the day [2][3] - Shareholders can vote either in person or via online platforms provided by the Shenzhen Stock Exchange [4][16] Attendance and Registration - Shareholders registered by the close of business on September 3, 2025, are eligible to attend [5][6] - Registration for attendance can be done in person or through authorized representatives [12][13] Agenda Items - The meeting will include proposals for amending the company's articles of association and electing a non-independent director [15][10] - A special resolution requires approval from at least two-thirds of the voting rights present [10][11] Voting Procedures - Voting will be conducted through both physical attendance and online systems, with specific time slots for online voting [3][18] - All proposals are non-cumulative voting items, and the first valid vote will be considered in case of duplicate votes [17][19] Additional Information - The company will not cover travel expenses for attending shareholders [20] - Contact information for inquiries is provided, including phone and fax numbers [21]

Core Viewpoint - The company is convening its first extraordinary general meeting of shareholders in 2025 to ensure the protection of shareholders' legal rights and maintain the order and efficiency of the meeting [1][2]. Meeting Details - The meeting is scheduled for July 31, 2025, at 13:30, located at the company's conference room in Shanghai [5]. - Voting will be conducted through a combination of on-site and online methods, with specific time slots for internet voting [5]. Meeting Agenda - The agenda includes sign-in, distribution of materials, and registration for speaking [6]. - The chairman will announce the number of attending shareholders and their voting rights before proceeding with the meeting [6]. Proposals for Consideration - Proposal 1: Election of a new non-independent director to replace the resigned director, with the candidate being Mao Xinyong [6][7]. - Proposal 2: Adjustment of the 2025 director remuneration plan, specifically for non-independent directors not holding executive positions, proposing a consultant allowance of RMB 100,000 per year [8]. - Proposal 3: Formulation and revision of certain internal governance systems, in compliance with relevant laws and regulations [9][10]. Additional Proposals - Several additional proposals regarding the management of various internal systems, including external guarantees, external investments, and fundraising management, are also set for discussion [10][11].